期刊文献+

心血管病患者血浆N端B型脑钠肽水平变化及其临床意义 被引量:38

Plasma NT-proBNP level and its clinical significance in patients with cardiovascular diseases
原文传递
导出
摘要 目的观察心血管病患者血浆N端B型脑钠肽(NTproBNP)浓度的改变并探讨其临床意义。方法用ELISA法测定1112例心血管病患者及60名健康体检者血浆NTproBNP浓度并分析其与美国纽约心脏病协会(NYHA)心功能分级的关系。结果心血管病患者组血浆LogNTproBNP浓度[(3.01±0.36)fmol/ml]显著高于健康对照组[(2.65±0.10)fmol/ml]且方差分析显示不同的心血管病患者组间血浆NTproBNP浓度差异亦有统计学意义(F=45.147,P<0.001)。各心血管病组血浆NTproBNP浓度随着心力衰竭程度的加重(NYHA心功能分级升高)而显著上升(P<0.001);但同为1级心功能或同为2级心功能时,不同心血管病组间的血浆NTproBNP浓度差异有统计学意义(P<0.001或P=0.001)。多因素相关分析表明血浆NTproBNP浓度与NYHA心功能分级和年龄之间具有良好的正相关性(r=0.712,P<0.001及r=0.063,P<0.001)。结论心血管病患者血浆NTproBNP浓度随着心力衰竭严重程度的增加而升高,是评价心功能的敏感指标;在心功能改变早期,不同心血管疾病对血浆NTproBNP水平的升高可能给予不同的贡献。 Objective To study the relationship of plasma NT-pro Brain Natriuretic Peptide (NT- proBNP) levels with cardiovascular diseases. Methods Plasma NT-proBNP concentrations of patients with cardiovascular disease (n = 1 112) and of normal controls (n = 60) were measured by enzyme-linked immunosorbent" assay (ELISA), and study the correlations of plasma NT-proBNP concentration with severity of heart failure, underling heart disease and New York Heart Association (NYHA) functional classifications in patients with cardiovascular disease. Results The plasma Log NT-proBNP concentrations of patients were significantly higher than those of the normal controls[ (3.01 ±0. 36 ) fmol/ml vs (2. 65 ±0. 10) fmol/ml, P 〈 0. 001 ]. Furthermore the concentrations of NT-proBNP between every 2 subgroups with different type cardiovascular diseases had significant differences and they also increased with the increased severity of heart failure according to NYHA functional classification (P 〈 0. 001 ). There are significant differences between every 2 subgroups with different type cardiovascular diseases among the patients with NYHA functional clase I or with clase 11 respectively. Multi-varietic regression analysis showed that there were significant positive correlations between NT-proBNP concentrations and NYHA functional classification, age (r = 0. 712, P 〈 0. 001 and r = 0. 063, P 〈 0. 001, respectively). Conclusion The plasma levels of NT-proBNP increase significantly with the increased severity of heart failure ( NYHA functional classes). At the early stage of cardiac function injury, different cardiovascular diseases may contribute to the increase of plasma NT-proBNP differently.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第1期31-34,共4页 Chinese Journal of Laboratory Medicine
关键词 N端B型脑钠肽 心血管疾病 酶联免疫吸附测定 心血管病患者 患者血浆 临床意义 脑钠肽 水平变化 B型 N端 NT-proBNP Cardiovascular diseases Enzyme-linked immunosorbent assay
作者简介 丛祥凤,电子信箱:xiangfeng_cong@yahoo.com.cn
  • 相关文献

参考文献9

  • 1Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology,2000,93 : 19-25.
  • 2Pemberton CJ, Johnson ML, Yandle TG, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.Hypertension ,2000,36 : 355-359.
  • 3Hammerer-Leacher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-temfinal pro-brain natriuretic peptide, brain natriuretic pepfide and N-temlinal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta, 2001,310:193-197.
  • 4Yoshihiko S, Teruyo Y. Application of NT-proBNP and BNP measurements in care : a more discerning marker for the detection and evaluation of heart failure. The European Journal of heart Failure,2004. 295-300.
  • 5史晓敏,林箐,徐国宾,宋以信,夏铁安.血清N末端B型钠尿肽原在心功能评价及慢性充血性心力衰竭诊断中的初步应用[J].中华检验医学杂志,2005,28(1):37-41. 被引量:77
  • 6Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997,350 : 1349-1353.
  • 7MeDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of lefi-ventricular systolic dysfunction. Lancet, 1998,351 : 9-13.
  • 8Redfield MM, Rodeheffer R J, Jacobsen S J, et al. Plasma brain natriuretic peptide concentration : impact of age and gender. J Am Coll Cardiol,2002 ,40 :976-982.
  • 9Richards AM, NichoUs MG, Espiner EA, et al. B -type natriuretic peptides and ejectionfraction for prognosis after myocardial infarction. Circulation, 2003,107:2786-2792.

二级参考文献10

  • 1史晓敏,宋以信,徐国宾,夏铁安.人血清N端脑钠肽水平参考值范围及其测定稳定性的初步调查[J].中国实验诊断学,2004,8(5):451-455. 被引量:18
  • 2Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol, 1997, 47:287 -296.
  • 3Yeo KT , Wu AH , Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338:107-115.
  • 4Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997, 350:1349-1353.
  • 5McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351:9-13.
  • 6Pfister R, Scholz M, Wielckens K, et al. Use of NT-proBNP in routing testing and comparison to BNP. Eur J Heart Fail, 2004, 6:289 -293.
  • 7Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail, 2004, 6:295-300.
  • 8McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev, 2003, 8:355 -358.
  • 9Richards AM , Nicholls MG , Yandle TG , et al. Plasma N-terminal pro-brain natriureitc peptide and adrenomedullin: new neurohormonal predictors of left ventriculation function and prognosis after myocardial infarction. Circulation, 1998, 97:1921-1929.
  • 10张国华,胡韵,史晓敏,徐国宾,夏铁安.B型钠尿肽的生物学特性及其在心脏病学中的临床应用进展[J].中华检验医学杂志,2004,27(4):262-265. 被引量:75

共引文献76

同被引文献325

引证文献38

二级引证文献248

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部